APA (7th ed.) Citation

N, U., F, D. G., A, D., M, O., G, M., M, P., . . . M, B. (2021). Host factors and history of SARS-CoV-2 infection impact the reactogenicity of BNT162b2 mRNA vaccine: Results from a cross-sectional survey on 7,014 workers in healthcare. European review for medical and pharmacological sciences, 25(24), 7985. https://doi.org/10.26355/eurrev_202112_27649

Chicago Style (17th ed.) Citation

N, Ughi, et al. "Host Factors and History of SARS-CoV-2 Infection Impact the Reactogenicity of BNT162b2 MRNA Vaccine: Results from a Cross-sectional Survey on 7,014 Workers in Healthcare." European Review for Medical and Pharmacological Sciences 25, no. 24 (2021): 7985. https://doi.org/10.26355/eurrev_202112_27649.

MLA (9th ed.) Citation

N, Ughi, et al. "Host Factors and History of SARS-CoV-2 Infection Impact the Reactogenicity of BNT162b2 MRNA Vaccine: Results from a Cross-sectional Survey on 7,014 Workers in Healthcare." European Review for Medical and Pharmacological Sciences, vol. 25, no. 24, 2021, p. 7985, https://doi.org/10.26355/eurrev_202112_27649.